0001209191-22-033930.txt : 20220603
0001209191-22-033930.hdr.sgml : 20220603
20220603151012
ACCESSION NUMBER: 0001209191-22-033930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harsanyi Zsolt
CENTRAL INDEX KEY: 0001380184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 22994066
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD., SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001380184
Harsanyi Zsolt
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
0
0
0
Common Stock
2022-06-01
4
M
0
298
A
4607
D
Restricted Stock Unit
2022-06-01
4
M
0
298
0.00
D
Common Stock
298
595
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
SoYoung Kwon, Attorney-in-Fact
2022-06-03
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints
SoYoung Kwon and Daphne Taylor as his true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as a director of Aptevo Therapeutics Inc. (the "Company"), Forms 3, 4, and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder, and any other forms or reports the undersigned may be required
to file in connection with the undersigned's ownership, acquisition, or
disposition of securities of the Company;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
or other form or report, and timely file such form or report with the U.S.
Securities and Exchange Commission and any stock exchange or similar authority;
and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned, pursuant to this Power of Attorney, shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in his
discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform each and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or his substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that no such attorney-in-fact, in serving in such capacity at the request of the
undersigned, is hereby assuming any of the undersigned's responsibilities to
comply with Section 13 and Section 16 of the Securities Exchange Act of 1934 and
the rules thereunder, as amended.
This Power of Attorney shall remain in full force and effect until revoked by
the undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 16th day of May, 2022.
/s/ Zsolt Harsanyi